Metformin	metformin	O	O
prevents	prevents	O	O
experimental	experimental	O	O
gentamicin-induced	gentamicin-induced	O	O
nephropathy	nephropathy	O	S_disease
by	by	O	O
a	a	O	O
mitochondria-dependent	mitochondria-dependent	O	O
pathway	pathway	O	O
.	.	O	O

The	the	O	O
antidiabetic	antidiabetic	O	O
drug	drug	O	O
metformin	metformin	O	O
can	can	O	O
diminish	diminish	O	O
apoptosis	apoptosis	O	O
induced	induced	O	O
by	by	O	O
oxidative	oxidative	O	O
stress	stress	O	O
in	in	O	O
endothelial	endothelial	O	O
cells	cells	O	O
and	and	O	O
prevent	prevent	O	O
vascular	vascular	O	O
dysfunction	dysfunction	O	O
even	even	O	O
in	in	O	O
nondiabetic	nondiabetic	O	O
patients	patients	O	O
.	.	O	O

Here	here	O	O
we	we	O	O
tested	tested	O	O
whether	whether	O	O
it	it	O	O
has	has	O	O
a	a	O	O
beneficial	beneficial	O	O
effect	effect	O	O
in	in	O	O
a	a	O	O
rat	rat	O	O
model	model	O	O
of	of	O	O
gentamicin	gentamicin	S_chemical	O
toxicity	toxicity	O	S_disease
.	.	O	O

Mitochondrial	mitochondrial	O	O
analysis	analysis	O	O
,	,	O	O
respiration	respiration	O	O
intensity	intensity	O	O
,	,	O	O
levels	levels	O	O
of	of	O	O
reactive	reactive	B_chemical	O
oxygen	oxygen	S_chemical	O
species	species	I_chemical	O
,	,	O	O
permeability	permeability	O	O
transition	transition	O	O
,	,	O	O
and	and	O	O
cytochrome	cytochrome	O	O
c	c	O	O
release	release	O	O
were	were	O	O
assessed	assessed	O	O
3	3	O	O
and	and	O	O
6	6	O	O
days	days	O	O
after	after	O	O
gentamicin	gentamicin	S_chemical	O
administration	administration	O	O
.	.	O	O

Metformin	metformin	O	O
treatment	treatment	O	O
fully	fully	O	O
blocked	blocked	O	O
gentamicin-mediated	gentamicin-mediated	O	O
acute	acute	O	B_disease
renal	renal	O	B_disease
failure	failure	O	I_disease
.	.	O	O

This	this	O	O
was	was	O	O
accompanied	accompanied	O	O
by	by	O	O
a	a	O	O
lower	lower	O	O
activity	activity	O	O
of	of	O	O
N-acetyl-beta-D-glucosaminidase	n-acetyl-beta-d-glucosaminidase	O	O
,	,	O	O
together	together	O	O
with	with	O	O
a	a	O	O
decrease	decrease	O	O
of	of	O	O
lipid	lipid	O	O
peroxidation	peroxidation	O	O
and	and	O	O
increase	increase	O	O
of	of	O	O
antioxidant	antioxidant	O	O
systems	systems	O	O
.	.	O	O

Metformin	metformin	O	O
also	also	O	O
protected	protected	O	O
the	the	O	O
kidney	kidney	O	O
from	from	O	O
histological	histological	O	O
damage	damage	O	O
6	6	O	O
days	days	O	O
after	after	O	O
gentamicin	gentamicin	S_chemical	O
administration	administration	O	O
.	.	O	O

These	these	O	O
in	in	O	O
vivo	vivo	O	O
markers	markers	O	O
of	of	O	O
kidney	kidney	O	O
dysfunction	dysfunction	O	O
and	and	O	O
their	their	O	O
correction	correction	O	O
by	by	O	O
metformin	metformin	O	O
were	were	O	O
complemented	complemented	O	O
by	by	O	O
in	in	O	O
vitro	vitro	O	O
studies	studies	O	O
of	of	O	O
mitochondrial	mitochondrial	O	O
function	function	O	O
.	.	O	O

We	we	O	O
found	found	O	O
that	that	O	O
gentamicin	gentamicin	S_chemical	O
treatment	treatment	O	O
depleted	depleted	O	O
respiratory	respiratory	O	O
components	components	O	O
(	(	O	O
cytochrome	cytochrome	O	O
c	c	O	O
,	,	O	O
NADH	nadh	O	O
)	)	O	O
,	,	O	O
probably	probably	O	O
due	due	O	O
to	to	O	O
the	the	O	O
opening	opening	O	O
of	of	O	O
mitochondrial	mitochondrial	O	O
transition	transition	O	O
pores	pores	O	O
.	.	O	O

These	these	O	O
injuries	injuries	O	O
,	,	O	O
partly	partly	O	O
mediated	mediated	O	O
by	by	O	O
a	a	O	O
rise	rise	O	O
in	in	O	O
reactive	reactive	B_chemical	O
oxygen	oxygen	S_chemical	O
species	species	I_chemical	O
from	from	O	O
the	the	O	O
electron	electron	O	O
transfer	transfer	O	O
chain	chain	O	O
,	,	O	O
were	were	O	O
significantly	significantly	O	O
decreased	decreased	O	O
by	by	O	O
metformin	metformin	O	O
.	.	O	O

Thus	thus	O	O
,	,	O	O
our	our	O	O
study	study	O	O
suggests	suggests	O	O
that	that	O	O
pleiotropic	pleiotropic	O	O
effects	effects	O	O
of	of	O	O
metformin	metformin	O	O
can	can	O	O
lessen	lessen	O	O
gentamicin	gentamicin	S_chemical	O
nephrotoxicity	nephrotoxicity	O	S_disease
and	and	O	O
improve	improve	O	O
mitochondrial	mitochondrial	O	O
homeostasis	homeostasis	O	O
.	.	O	O

